# 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication

> **NCT01464060** · PHASE4 · UNKNOWN · sponsor: **Infante, Javier Molina, M.D.** · enrollment: 400 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** PPI, amoxicillin, metronidazole and clarithromycin
- **DRUG:** PPI, amoxicillin, metronidazole and clarithromycin

## Key facts

- **NCT ID:** NCT01464060
- **Lead sponsor:** Infante, Javier Molina, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2012-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01464060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01464060, "14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01464060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*